(HealthDay)—Effective screening, diagnosis, and management strategies are needed for patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), according to a special report published ...
Jul 26, 2021
0
49
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and can progress to liver cirrhosis, liver failure or cancer. Currently, nonalcoholic steatohepatitis (NASH) diagnosis requires an invasive ...
Jun 17, 2021
0
3
There are no approved drugs to treat nonalcoholic fatty liver disease but controlling blood sugar over time may help decrease the risk of liver scarring and disease progression.
May 19, 2021
0
14
Nonalcoholic fatty liver disease (NAFLD) is a pathological condition characterized by excessive fat stored in the liver that is not attributed to heavy alcohol consumption, which can lead to liver failure and even cancer. ...
Mar 24, 2021
0
2
Nonalcoholic fatty liver disease (NAFLD) is a widespread condition in the Western World. Around 30% of the population have lipid droplets stored in their liver which diminish its function in the long term. Main causes for ...
Jan 25, 2021
0
4
Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is ...
Nov 24, 2020
0
157
A review article authored by a researcher at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggests that following menopause, women are at higher risk for developing nonalcoholic fatty ...
Aug 14, 2020
0
3
Diabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications. NAFLD affects over 30% of Americans, and is characterized as a fatty liver, which can progress ...
Jul 31, 2020
0
2
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease worldwide, affecting an estimated one-quarter of the global population. It is a progressive condition that, in worst cases, can lead to ...
Jun 30, 2020
0
105
A team of Penn State researchers developed a first-of-its-kind clinical trial to test the use of exercise as a treatment for patients with a severe form of nonalcoholic fatty liver disease.
Jun 8, 2020
0
4
